FENLEST
DEAD

Serial Number

77327117

Owner

LifeCycle Pharma A/S

Attorney

Bassam N. Ibrahim

Filing Date

Nov 12, 2007

Add to watchlist:

No watchlists yet
View on USPTO

FENLEST Trademark

Serial Number: 77327117

FENLEST is a trademark filed by LifeCycle Pharma A/S on November 12, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

LifeCycle Pharma A/S (18 trademarks)

Kogle Alle 4
Horsholm 2970 , DK

Entity Type: 99

Trademark Details

Filing Date

November 12, 2007

Registration Date

Not Registered

Goods & Services

educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical, and pharmaceutical fields

treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical or medical preparations, compounds or substances for use in the pharmaceutical and medical industries

pharmaceutical preparations; medical preparations; and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, and capsules; all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain

scientific research, namely, bacteriological research, biological research, biotechnological research, scientific research services for medical purposes and scientific research consultation; research and development for new products for others; designing and development of medical equipment; industrial design services; pharmaceutical and medical consultation regarding pharmaceutical drug development services; cosmetic research for others; design services for others in the field of medical packaging and equipment; medical research; medical and scientific research, namely, conducting clinical trials, namely, testing of medical substances and testing of medical applications; pharmaceutical drug development services, namely, development of medical applications, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations and consultation regarding pharmaceutical formulation; development of drug delivery systems for others, namely, development of solid dosage forms, pharmaceutical controlled release systems, modified release systems and pharmaceutical modified release systems and consultation related thereto; pharmaceutical drug development services, namely, development of mixing technology, development of particulate material, development of particulate material mixing technology, development of granulate technology, development of tableting technology, and consultation related thereto; materials testing for the pharmaceutical and medical industries

Filing History

ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Oct 9, 2008 MAB5
ABANDONMENT - AFTER PUBLICATION
Oct 9, 2008 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Oct 6, 2008 EXAR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2008 PREV
ASSIGNED TO LIE
Sep 27, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 17, 2008 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 30, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 30, 2008 GNSL
SUSPENSION LETTER WRITTEN
Jul 30, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2008 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2008 DOCK
NEW APPLICATION ENTERED
Nov 15, 2007 NWAP